[Form 4] HORACE MANN EDUCATORS CORP /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Marita Zuraitis, President & CEO and a director of Horace Mann Educators Corp (HMN), reported a sale of 5,000 shares of Common Stock on 10/01/2025 at a price of $44.81. The Form 4 states the sale was effected under a Rule 10b5-1 trading plan adopted on 11/18/2024. After the reported transaction, the filing shows beneficial ownership of 293,788.422 shares, which the filer explains represents 212,474.422 vested restricted stock units and 81,314 shares of Common Stock. The Form 4 was signed by an attorney-in-fact on 10/03/2025.

Positive

• Sale executed under a Rule 10b5-1 plan, indicating the transaction follows a pre-established, documented trading arrangement
• Reporting compliance: Form 4 filed and signed promptly (transaction 10/01/2025; signature 10/03/2025)

Negative

• Insider sale of 5,000 shares by the President & CEO may be viewed unfavorably by some investors
• Significant portion of holdings are vested RSUs (212,474.422 vested RSUs), which can convert to sellable shares

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ZURAITIS MARITA

(Last) (First) (Middle)

1 HORACE MANN PLAZA

(Street)

SPRINGFIELD IL 62715

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HORACE MANN EDUCATORS CORP /DE/ [ HMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	10/01/2025		S		5,000	D	$44.81	293,788.422(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024.

2. Represents 212,474.422 vested restricted stock units and 81,314 shares of Common Stock.

Remarks:

	Linea K. Michael, Attorney in Fact for Marita Zuraitis	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HMN insider Marita Zuraitis report on Form 4?

The Form 4 reports a sale of 5,000 shares at $44.81 on 10/01/2025, executed under a Rule 10b5-1 trading plan adopted on 11/18/2024.

How many HMN shares does Marita Zuraitis beneficially own after the sale?

The filing shows beneficial ownership of 293,788.422 shares, comprised of 212,474.422 vested restricted stock units and 81,314 common shares.

Was the HMN sale pre-planned or a discretionary trade?

According to the Form 4, the sale was effected under a Rule 10b5-1 trading plan, indicating it was pre-established on 11/18/2024.

When was the Form 4 for HMN signed and filed?

The Form 4 shows the signature by an attorney-in-fact on 10/03/2025 following the 10/01/2025 transaction.

What portion of Zuraitis's holdings are vested restricted stock units (RSUs)?

The Form 4 discloses 212,474.422 vested RSUs as part of the total beneficial ownership.